Page 1

FOR IMMEDIATE RELEASE Media Contact Steve Brett , ( 224 ) 948-5353 media@baxter.com Investor Contact Clare Trachtman , ( 224 ) 948-3020 • • • Baxter BAXTER REPORTS FIRST - QUARTER 2021 RESULTS First - quarter revenue of $ 2.9 billion increased 5 % on a reported basis and 1 % on both a constant currency and operational basis¹ First - quarter U.S. GAAP earnings per share ( EPS ) of $ 0.58 declined 9 % ; Adjusted EPS of $ 0.76 declined 7 % Baxter expects full - year 2021 sales growth of 8 % to 9 % on a reported basis , 5 % to 6 % on a constant currency basis and 4 % to 5 % on an operational basis Baxter expects full - year U.S. GAAP EPS of $ 2.85 to $ 2.93 and adjusted EPS of $ 3.47 to $ 3.55 DEERFIELD , III . , APRIL 29 , 2021 - Baxter International Inc. ( NYSE : BAX ) , a leading global medical products company , today reported results for the first quarter of 2021 . " Baxter's medically essential products are fundamental to healthcare , and many have proven pivotal in the fight against COVID - 19 , " said José ( Joe ) E. Almeida , chairman , president and chief executive officer . “ Our life - sustaining portfolio , broad geographic reach and the ongoing momentum of our business transformation are all keys to our resilience . We are well positioned to strengthen our impact in the year ahead , fueled by our innovative product pipeline , relentless focus on execution , and capital deployment opportunities to benefit patients , customers and investors . " First - Quarter Financial Results Worldwide sales in the first quarter totaled approximately $ 2.9 billion , an increase of 5 % on a reported basis and 1 % on both a constant currency and operational basis . Operational sales in the 1 See tables to the press release for reconciliations of non - GAAP measures used in this press release to the corresponding U.S. GAAP measures .